Press Release

In patients suffering from Wet Age related Macular Degeneration, abnormal blood vessels grow under the retina and macula. These new blood vessels may then bleed and leak fluid, causing the macula to bulge or lift up from its normally flat position, thus distorting or destroying central vision resulting in rapid and severe vision loss. The wet/ neovascular type affects approximately 10-15% of individuals with age-related macular degeneration, but accounts for approximately 90% of all cases of severe vision loss from the disease.

 

Request for Sample Pages: 

https://www.delveinsight.com/sample-request/wet-age-related-macular-degeneration-wet-amd-epidemiology-forecast

 

DelveInsight’s ‘Wet Age-Related Macular Degeneration Epidemiology Forecast to 2030‘ report delivers an in-depth understanding of the disease, historical and forecasted Wet Age-Related Macular Degeneration epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

The DelveInsight Wet Age-Related Macular Degeneration epidemiology report gives a thorough understanding of the Wet Age-Related Macular Degeneration by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Wet Age-Related Macular Degeneration in the US, Europe, and Japan. The report covers the detailed information of the Wet Age-Related Macular Degeneration epidemiology scenario in seven major countries (US, EU5, and Japan).

Key Highlights Of The Report

  • The number of people living with macular degeneration is expected to reach 196 million worldwide by 2020 and increase to 288 million by 2040.
  • The number of neovascular AMD cases in the UK is predicted to rise by 59% from 2015 to 2035
  • Nearly 11 million Americans have some form of macular degeneration, while 1.1 million or 10% of those Americans have wet AMD
  • The National Eye Institute (NEI) states that women generally are more susceptible to develop age-related eye diseases, such as AMD. In 2010, 65 percent of total AMD cases were in women as compared to 35 percent in men.
  • Approximately 200,000 new cases of Wet AMD are diagnosed each year in the U.S and Wet AMD results in the cause of 90% of AMD-related severe vision loss.

 

Wet Age-Related Macular Degeneration Epidemiology

  • Delveinsight’s Wet Age-Related Macular Degeneration epidemiology division provides insights about historical and current patient pool and forecasted trends for every seven major countries. 
  • The Wet Age-Related Macular Degeneration epidemiology data are studied through all possible divisions to give a better understanding of the Disease scenario in 7MM. 
  • The Wet Age-Related Macular Degeneration epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. 
  • It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

 

Scope of the Report

  • The report provides insight into the historical and forecasted patient pool of Wet Age-Related Macular Degeneration in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.
  • The report assesses the disease risk and burden and highlights the unmet needs of Wet Age-Related Macular Degeneration.
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population.
  • The Wet Age-Related Macular Degeneration report provides a detailed overview explaining Wet Age-Related Macular Degeneration causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns.
  • The Wet Age-Related Macular Degeneration Epidemiology Report and Model provide an overview of the risk factors and global trends of Wet Age-Related Macular Degeneration in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan).
  • The report provides the segmentation of the Wet Age-Related Macular Degeneration epidemiology. 

 

Key Benefit of Wet Age-Related Macular Degeneration Epidemiology Report 

The Wet Age-Related Macular Degeneration Epidemiology report will allow the user to –

  • Develop business strategies by understanding the trends shaping and driving the global Wet Age-Related Macular Degeneration market
  • Quantify patient populations in the global Wet Age-Related Macular Degeneration market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Wet Age-Related Macular Degeneration therapeutics in each of the markets covered
  • Understand the magnitude of Wet Age-Related Macular Degeneration population by its epidemiology
  • The Wet Age-Related Macular Degeneration Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

 

Request for Sample Pages: 

https://www.delveinsight.com/sample-request/wet-age-related-macular-degeneration-wet-amd-epidemiology-forecast

 

Table of Contents

  1. Key Insights 
  2. Executive Summary of Wet Age-Related Macular Degeneration
  3. Wet Age-Related Macular Degeneration Disease Background and Overview
  4. Wet Age-Related Macular Degeneration Patient Journey
  5. Wet Age-Related Macular Degeneration Epidemiology and Patient Population
  6. Wet Age-Related Macular Degeneration Treatment Algorithm, Current Treatment, and Medical Practices
  7. KOL Views on Wet Age-Related Macular Degeneration 
  8. Wet Age-Related Macular Degeneration Unmet Needs
  9. Appendix
  10. DelveInsight Capabilities
  11. Disclaimer

*The table of contents is not exhaustive; will be provided in the final report

 

About  DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.

Related Reports

Wet Age-Related Macular Degeneration (Wet AMD) Market Insight, Epidemiology and Market Forecast -2030

DelveInsight’ s Wet Age-Related Macular Degeneration (Wet AMD) – Market Insights, Epidemiology and Market Forecast – 2030 report provides the detailed overview of the disease and in depth understanding of historical and forecasted epidemiology.

 

Wet Age-Related Macular Degeneration (Wet AMD) – Pipeline Insights, 2020

Wet Age-Related Macular Degeneration (Wet AMD) Pipeline Insight, 2020 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Wet Age-Related Macular Degeneration (Wet AMD) market.

 

Contact us:

Shruti Thakur

[email protected] 

+91-9650213330

https://www.delveinsight.com/

https://www.delveinsight.com/report-store/wet-age-related-macular-degeneration-wet-amd-epidemiology-forecast